loading

Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten

pulisher
10:49 AM

Using fundamentals and technicals on Gyre Therapeutics Inc.Stop Loss & Fast Gain Stock Trading Tips - newser.com

10:49 AM
pulisher
10:12 AM

Using Ichimoku Cloud for Gyre Therapeutics Inc. technicalsLayoff News & Safe Entry Zone Tips - newser.com

10:12 AM
pulisher
06:12 AM

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up – Should You Buy? - Defense World

06:12 AM
pulisher
05:28 AM

What momentum shifts mean for Gyre Therapeutics Inc.2025 Dividend Review & Technical Buy Zone Confirmation - newser.com

05:28 AM
pulisher
01:42 AM

Will breakout in Gyre Therapeutics Inc. lead to full recoveryGap Up & Fast Entry Momentum Trade Alerts - newser.com

01:42 AM
pulisher
01:05 AM

What dividend safety score for Gyre Therapeutics Inc. stockPortfolio Gains Summary & Safe Entry Zone Identification - newser.com

01:05 AM
pulisher
Oct 11, 2025

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpHere's Why - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Gyre Therapeutics Stock Price, Quotes and Forecasts - Benzinga

Oct 10, 2025
pulisher
Oct 10, 2025

Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target By Investing.com - Investing.com Nigeria

Oct 10, 2025
pulisher
Oct 10, 2025

Visual trend scoring systems applied to Gyre Therapeutics Inc.2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Oct 10, 2025
pulisher
Oct 10, 2025

Jefferies Initiates Coverage on Gyre Therapeutics (GYRE) with a "Buy" Rating | GYRE Stock News - GuruFocus

Oct 10, 2025
pulisher
Oct 10, 2025

Jefferies Initiates Coverage of Gyre Therapeutics (GYRE) with Buy Recommendation - Nasdaq

Oct 10, 2025
pulisher
Oct 10, 2025

Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target - Investing.com

Oct 10, 2025
pulisher
Oct 09, 2025

Gyre Therapeutics (NASDAQ:GYRE) Earns Sell (D) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 07, 2025

Gyre Therapeutics Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Small Investment Portfolio - earlytimes.in

Oct 07, 2025
pulisher
Oct 05, 2025

Can momentum traders help lift Gyre Therapeutics Inc.Weekly Trend Report & Safe Entry Point Identification - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Gyre Therapeutics Inc. stock outlook for YEARJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Volatility clustering patterns for Gyre Therapeutics Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 01, 2025

Real time alert setup for Gyre Therapeutics Inc. performanceTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Gyre Therapeutics president Ma Songjiang sells $42,760 in stock - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Discovering 3 Undiscovered Gems In The US Market - simplywall.st

Sep 30, 2025
pulisher
Sep 30, 2025

Goldman Sachs Group Inc. Cuts Stock Position in Gyre Therapeutics, Inc. $GYRE - Defense World

Sep 30, 2025
pulisher
Sep 29, 2025

Developing predictive dashboards with Gyre Therapeutics Inc. dataPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What analysts say about Gyre Therapeutics Inc stockStock Valuation Metrics & Free Quantitative Trading Strategies - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

Gyre Therapeutics president sells $45,380 in stock - MSN

Sep 28, 2025
pulisher
Sep 28, 2025

Is Gyre Therapeutics Inc a good long term investmentEarnings Forecast Updates & Free Dynamic Capital Growth - earlytimes.in

Sep 28, 2025
pulisher
Sep 25, 2025

Financial Survey: Theratechnologies (NASDAQ:THTX) vs. Gyre Therapeutics (NASDAQ:GYRE) - Defense World

Sep 25, 2025
pulisher
Sep 24, 2025

Does Gyre Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Fed Impact & Stock Portfolio Risk Management - newser.com

Sep 24, 2025
$84.81
price up icon 1.12%
$22.95
price up icon 7.63%
$32.66
price up icon 2.66%
$102.75
price up icon 0.67%
$164.59
price up icon 1.50%
biotechnology ONC
$331.58
price up icon 3.40%
Kapitalisierung:     |  Volumen (24h):